Abstract:Genome-wide association studies (GWAS) have been successful in finding associations between specific genetic variants and cancer susceptibility in human populations. These studies have identified a range of highly statistically significant associations between single nucleotide polymorphisms (SNPs) and susceptibility to development of a range of human tumors. However, the effect of each SNP in isolation is very small, and all of the SNPs combined only account for a relatively minor proportion of the total genetic risk (5-10%). There is therefore a major requirement for alternative routes to the discovery of genetic risk factors for cancer. We have previously shown using mouse models that chromosomal regions harboring susceptibility genes identified by linkage analysis frequently exhibit allele-specific genetic alterations in tumors. We demonstrate here that the Fbxw7 gene, a commonly mutated gene in a wide range of mouse and human cancers, shows allele-specific deletions in mouse lymphomas and skin tumors. Lymphomas from three different F1 hybrids show 100% allele-specificity in the patterns of allelic loss. Parental alleles from 129/Sv or Spretus/Gla mice are lost in tumors from F1 hybrids with C57BL/6 animals, due to the presence of a specific non-synonymous coding sequence polymorphism at the N-terminal portion of the gene. A specific genetic test of association between this SNP and lymphoma susceptibility in interspecific backcross mice showed a significant linkage (p = 0.001), but only in animals with a functional p53 gene. These data therefore identify Fbxw7 as a p53-dependent tumor susceptibility gene. Increased p53-dependent tumor susceptibility and allele-specific losses were also seen in a mouse skin model of skin tumor development. We propose that analysis of preferential allelic imbalances in tumors may provide an efficient means of uncovering genetic variants that affect mouse and human tumor susceptibility.

A Subset of Skin Tumor Modifier Loci Determines Survival Time of Tumor-Bearing Mice.

Allele-Specific Hras Mutations And Genetic Alterations At Tumor Susceptibility Loci In Skin Carcinomas From Interspecific Hybrid Mice

Characterization of M6a-Related Genes Landscape in Skin Cutaneous Melanoma to Aid Immunotherapy and Assess Prognosis

Genome-wide Screening of Aberrant DNA Methylation Which Associated with Gene Expression in Mouse Skin Cancers.

Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice.

Data from Genome-Wide Association and Fine Mapping of Genetic Loci Predisposing to Colon Carcinogenesis in Mice

Genetic Variants of Tgfb1 Act As Context-Dependent Modifiers of Mouse Skin Tumor Susceptibility

Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.

Identification of Las2, a Major Modifier Gene Affecting the Pas1 Mouse Lung Tumor Susceptibility Locus.

Screening Mouse Mutations for Resistance to Cancer Metastasis

Identification of Immune-Related Biomarkers Associated with Tumorigenesis and Prognosis in Skin Cutaneous Melanoma.

Genetic Variants of EML1 and HIST1H4E in Myeloid Cell-Related Pathway Genes Independently Predict Cutaneous Melanoma-Specific Survival

Allele-Specific Deletions in Mouse Tumors Identify Fbxw7 As Germline Modifier of Tumor Susceptibility

A Mouse Skin Multistage Carcinogenesis Model Reflects The Aberrant Dna Methylation Patterns Of Human Tumors

Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis.

Resistance to Carcinogenesis in the African Spiny Mouse (Acomys) correlates with upregulation of tumor suppressor genes.

Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma.

Transposon Insertional Mutagenesis In Mice Identifies Human Breast Cancer Susceptibility Genes And Signatures For Stratification

Genetic Variants of SDCCAG8 and MAGI2 in Mitosis‐related Pathway Genes Are Independent Predictors of Cutaneous Melanoma‐specific Survival

Genetic Variants in the Genes Encoding Rho Gtpases and Related Regulators Predict Cutaneous Melanoma-Specific Survival

Novel Genetic Variants of PIP5K1C and MVB12B of the Endosome-Related Pathway Predict Cutaneous Melanoma-Specific Survival